This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Centre Hospitalier Regional Et Universitaire De Lille (Chru), Université De Lille 2 Droit Et Santé. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 10 
2 out of 13 Years Active: 2019-2020
Title: Hélène Zephir: Innovator in Neurodegenerative Disease Treatment
Introduction
Hélène Zephir is a prominent inventor based in Lille, France. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. With a total of 2 patents to her name, her work is paving the way for new therapeutic options.
Latest Patents
Hélène's latest patents focus on novel compounds and their pharmaceutical compositions aimed at treating neurodegenerative diseases. The inventions are directed to compounds of Formula (I), including pharmaceutically acceptable salts or solvates thereof, and their various uses in medical applications.
Career Highlights
Throughout her career, Hélène has been associated with esteemed institutions such as Université de Lille 2 Droit et Santé and Centre Hospitalier Regional et Universitaire de Lille (CHRU). Her work in these organizations has allowed her to advance her research and contribute to the scientific community.
Collaborations
Hélène has collaborated with notable colleagues, including Patricia Melnyk and Patrick Vermersch. These partnerships have enriched her research and expanded the impact of her inventions.
Conclusion
Hélène Zephir's innovative work in the pharmaceutical field highlights her dedication to improving treatments for neurodegenerative diseases. Her contributions are essential in the ongoing quest for effective medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile